Libra Infusions Limited (DSE:LIBRAINFU)
Bangladesh · Delayed Price · Currency is BDT 630.80
-4.90 (-0.77%)
At close: Jan 20, 2026
Libra Infusions Market Cap
Libra Infusions has a market cap or net worth of 1.41 billion as of January 23, 2026. Its market cap has decreased by -25.64% in one year.
Market Cap
1.41B
Enterprise Value
n/a
Revenue
197.03M
Ranking
n/a
PE Ratio
889.83
Stock Price
630.80
Market Cap Chart
Since December 7, 2006, Libra Infusions's market cap has increased from 57.04M to 1.41B, an increase of 2,371.22%. That is a compound annual growth rate of 18.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 1.41B | -1.34% |
| Dec 30, 2025 | 1.43B | -20.12% |
| Dec 30, 2024 | 1.79B | -13.77% |
| Dec 28, 2023 | 2.07B | 61.06% |
| Dec 29, 2022 | 1.29B | -11.82% |
| Dec 30, 2021 | 1.46B | 51.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asiatic Laboratories | 6.66B |
| Orion Pharma | 6.51B |
| Navana Pharmaceuticals | 5.80B |
| Techno Drugs | 4.04B |
| Ambee Pharmaceuticals | 1.70B |
| Pharma Aids | 1.57B |
| Silco Pharmaceuticals | 1.47B |
| Indo-Bangla Pharmaceuticals | 1.42B |